SARS-CoV-2–Specific B Cell Detection and Therapeutic Antibody Discovery
To combat the COVID-19 pandemic, comprehensive characterization of humoral and cellular immune responses to SARS-CoV-2 is essential.
At Miltenyi Biotec, we have developed reliable tools and methods for analyzing and enriching rare populations of SARS-CoV-2–specific B cells. Learn how our products and protocols facilitate COVID-19 research and support the discovery and development of therapeutic antibodies against SARS-CoV-2 and other diseases in this webinar.
Attend this webinar to:
- Understand how antigen-specific lymphocytes work together against SARS-CoV-2
- Learn about tools and protocols for monitoring and researching SARS-CoV-2–specific B cells
- Explore the generation of monoclonal antibodies from antigen-specific B cells
Dr Susanne Bethke
Global Product Manager for B Cell Immunology, Miltenyi Biotec